Satellos Bioscience Inc. (MSCL) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Satellos Bioscience Inc. stock C$6.52, price C$9.19, that is 29.1% below the price, quality 30 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Satellos Bioscience Inc.
MSCL · TOExpensive (fair value 29% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.
How to read this chart
60‑month range C$2.64 – C$26.40 · fair‑value band C$4.89 – C$8.15 · the C$9.19 price screens above the C$6.52 fair value. As of Nov 15, 2026.
Every Wednesday you see whether Satellos Bioscience is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.
Show moreShow less
The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease.
The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
Stock analysis
Satellos Bioscience Inc. (MSCL) currently trades at C$9.19, while our estimate is C$6.52, 29% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: C$4.89 (bear) to C$8.15 (bull), the price of C$9.19 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 30/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
Satellos Bioscience Inc. reported revenue of $0 in FY2025 versus $0 in FY2021. Reported net income was −$25.3M in FY2025.
Key figures
Market cap C$191M (≈ $134M) Micro · EPS (TTM) C$−2.70 · Return on equity −70.5% · Return on assets (EBIT) −69.3% (5-year average) · Free cash flow −$24.0M · Net cash $9.8M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 8 out of 100 (low confidence).
What moves the price
The share trades about 49% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −29%, MSCL screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare Satellos Bioscience Inc. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 850 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Stock screener with 62 metrics
- Undervalued stocks: Canadian Stocks
- Valuation of the Canada market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $952.40 | $1,275 | +34% | vs MSCL |
| Vertex Pharmaceuticals Incorporated VRTX | $537.79 | $592.46 | +10% | vs MSCL |
| Samsung Biologics Co 207940 | 1,414,000 KRW | 1,552,100 KRW | +10% | vs MSCL |
| argenx SE ARGX | $950.95 | $908.40 | −4% | vs MSCL |
| CSL Limited CSL | A$199.55 | A$186.49 | −7% | vs MSCL |
| Moderna, Inc MRNA | $215.27 | $135.64 | −37% | vs MSCL |
| BeOne Medicines AG 6160 | HK$247.40 | HK$152.92 | −38% | vs MSCL |
| Revolution Medicines, Inc RVMD | $166.87 | $88.78 | −47% | vs MSCL |
| Celltrion, Inc 068270 | 213,000 KRW | 74,945 KRW | −65% | vs MSCL |
| Royalty Pharma plc RPRX | $68.53 | $19.01 | −72% | vs MSCL |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Satellos Bioscience Inc. (MSCL) overvalued or undervalued?
What is the fair value of MSCL?
What is the quality score of MSCL?
What is the price target for Satellos Bioscience Inc. (MSCL)?
What is the Satellos Bioscience Inc. stock forecast for 2026?
What is the intrinsic value of Satellos Bioscience Inc. (MSCL)?
Is Satellos Bioscience Inc. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of MSCL?
How much is Satellos Bioscience Inc. worth?
What do the bullish and bearish scenarios say about MSCL?
How solid is the balance sheet of Satellos Bioscience Inc. (MSCL)?
How far is MSCL from its 52-week high?
Which stocks are comparable to Satellos Bioscience Inc.?
Is Satellos Bioscience Inc. stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Satellos Bioscience Inc. (MSCL)?
What should I pay attention to with Satellos Bioscience Inc. right now?
Key figures of Satellos Bioscience Inc.
How large is the market capitalisation of Satellos Bioscience Inc. (MSCL)?
What are the earnings per share of Satellos Bioscience Inc. (MSCL)?
What is the return on equity of Satellos Bioscience Inc. (MSCL)?
What is the EBIT return on assets of Satellos Bioscience Inc. (MSCL)?
How much free cash flow does Satellos Bioscience Inc. (MSCL) generate?
How much net cash does Satellos Bioscience Inc. (MSCL) hold?
Watch Satellos Bioscience Inc. in the live analysis
One click puts Satellos Bioscience Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.